Stemtech Corporation
STEK · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.03 | 0.01 | 0.01 | 0.07 |
| FCF Yield | -10.94% | -75.05% | -30.07% | -2.15% |
| EV / EBITDA | -5.09 | 128.88 | -1.30 | 58.09 |
| Quality | ||||
| ROIC | 169.10% | -460.03% | 269.28% | 125.63% |
| Gross Margin | 73.75% | 79.65% | 74.47% | 76.32% |
| Cash Conversion Ratio | 0.16 | 0.37 | 0.14 | 0.27 |
| Growth | ||||
| Revenue 3-Year CAGR | 3.49% | 4.43% | 1.31% | -13.24% |
| Free Cash Flow Growth | 70.47% | -67.30% | 36.42% | -587.74% |
| Safety | ||||
| Net Debt / EBITDA | -2.00 | 73.35 | -0.29 | 0.40 |
| Interest Coverage | -1.51 | -0.86 | -1.23 | -0.39 |
| Efficiency | ||||
| Inventory Turnover | 6.72 | 20.73 | 7.36 | 2.34 |
| Cash Conversion Cycle | -1,169.63 | -964.96 | -1,012.71 | -1,288.49 |